Related Experiment Video
Updated: Jun 6, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Integrin signalling adaptors: not only figurants in the cancer story
Sara Cabodi1, Maria del Pilar Camacho-Leal, Paola Di Stefano
1Molecular Biotechnology Centre and Department of Genetics, Biology and Biochemistry, University of Torino, Via Nizza 52, Torino 10126, Italy.
Abstract:
Current evidence highlights the ability of adaptor (or scaffold) proteins to create signalling platforms that drive cellular transformation upon integrin-dependent adhesion and growth factor receptor activation. The understanding of the biological effects that are regulated by these adaptors in tumours might be crucial for the identification of new targets and the development of innovative therapeutic strategies for human cancer. In this Review we discuss the relevance of adaptor proteins in signalling that originates from integrin-mediated cell-extracellular matrix (ECM) adhesion and growth factor stimulation in the context of cell transformation and tumour progression. We specifically underline the contribution of p130 Crk-associated substrate (p130CAS; also known as BCAR1), neural precursor cell expressed, developmentally down-regulated 9 (NEDD9; also known as HEF1), CRK and the integrin-linked kinase (ILK)-pinch-parvin (IPP) complex to cancer, along with the more recently identified p140 Cas-associated protein (p140CAP; also known as SRCIN1).
Insights
Adaptor proteins form signaling platforms crucial for cell transformation and tumor progression. Understanding their role in cancer is key for developing novel therapeutic strategies targeting these key signaling molecules.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Adaptor proteins act as signaling platforms, integrating signals from cell adhesion and growth factor receptors.
- These signaling pathways are critical for cellular transformation and tumor progression.
Purpose of the Study:
- To review the role of adaptor proteins in cancer development.
- To highlight specific adaptor proteins involved in integrin-mediated and growth factor-stimulated signaling in cancer.
- To discuss the potential of these adaptors as therapeutic targets.
Main Methods:
- Literature review of current evidence on adaptor proteins in cancer signaling.
- Focus on specific adaptor proteins: p130CAS (BCAR1), NEDD9 (HEF1), CRK, the ILK-PINCH-PARVIN (IPP) complex, and p140CAP (SRCIN1).
Main Results:
- Adaptor proteins are central to signaling pathways driving cell transformation and tumor progression.
- Specific adaptor proteins like p130CAS, NEDD9, CRK, IPP complex, and p140CAP are implicated in various cancers.
- Their involvement in integrin-ECM adhesion and growth factor signaling is crucial for cancer development.
Conclusions:
- Adaptor proteins are vital regulators of cancer cell transformation and progression.
- Targeting these adaptor proteins offers promising avenues for novel cancer therapies.
- Further research into adaptor protein function can lead to innovative therapeutic strategies.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cancer Cell Migration through Invadopodia
Selectins
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

